Therapeutic Potential of PARP Inhibitors in the Treatment of Gastrointestinal Cancers
Gastrointestinal (GI) malignancies are a major global health burden, with high mortality rates. The identification of novel therapeutic strategies is crucial to improve treatment and survival of patients. The poly (ADP-ribose) polymerase (PARP) enzymes involved in the DNA damage response (DDR) play...
Furkejuvvon:
| Váldodahkkit: | , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
MDPI AG
2021-08-01
|
| Ráidu: | Biomedicines |
| Fáttát: | |
| Liŋkkat: | https://www.mdpi.com/2227-9059/9/8/1024 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|